FDA Issues Complete Response Letter for neffy® (epinephrine nasal spray) New Drug Application with Request for Additional Study
Company aligned with FDA in August 2023 on both physician labeling and post-market requirements, which…
Month: September 2023
Bioventus to Present at the Cantor Global Healthcare Conference
DURHAM, N.C., Sept. 19, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS), a global leader…
R.T. Weatherman Foundation Unveils Dynamic Rebrand and New Website, Deepening Commitment to Global Democracy and Aid
KYIV, UKRAINE / ACN Newswire / September 20, 2023 / Recognized as the “last mile…
Moody’s Launches VIS Rating in Partnership with Vietnam’s Leading Financial institutions
NEW YORK–(BUSINESS WIRE)–Moody’s Corporation (NYSE:MCO) today announced the launch of Vietnam Investors Service And Credit…
HilleVax Announces Pricing of Public Offering of Common Stock
BOSTON, Sept. 19, 2023 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company…
Afterparty Secures $5M in Funding to Debut Afterparty AI; Enables Creators to Infinitely Scale Fan Interactions
LOS ANGELES–(BUSINESS WIRE)–Afterparty, the platform empowering thousands of creators with the tools and technology for…
USISPF, ReNew and the Consulate General of India Bring Together Business and Government Leaders to Discuss U.S.- India Climate Partnership
NEW YORK–(BUSINESS WIRE)–$RNW #ClimatePartnership–The US-India Strategic Partnership Forum (USISPF), and ReNew, in partnership with the…
Columbia Sportswear Company Releases 2022 Impact Report
PORTLAND, Ore.–(BUSINESS WIRE)–Columbia Sportswear Company (NASDAQ: COLM) (the “Company”), a global leading innovator in outdoor, active…
Nanobiotix to Announce Half Year 2023 Financial Results on September 26, 2023
Conference Call and Webcast to be Held at 8:00 AM EDT / 2:00 PM CEST…
Nanobiotix to Announce Half Year 2023 Financial Results on September 26, 2023
Conference Call and Webcast to be Held at 8:00 AM EDT / 2:00 PM CEST…
HilleVax Announces Proposed Public Offering of Common Stock
BOSTON, Sept. 19, 2023 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company…
HilleVax Announces Proposed Public Offering of Common Stock
BOSTON, Sept. 19, 2023 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company…
Eagle Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023
WOODCLIFF LAKE, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle”…
Eagle Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023
WOODCLIFF LAKE, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle”…
Assembly Biosciences to Highlight Pipeline Progress in HBV and HDV at the 2023 International HBV Meeting
— Two oral presentations and one poster will feature new data from the Company’s hepatitis…
Assembly Biosciences to Highlight Pipeline Progress in HBV and HDV at the 2023 International HBV Meeting
— Two oral presentations and one poster will feature new data from the Company’s hepatitis…
Vaxcyte to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference
SAN CARLOS, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage…
Vaxcyte to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference
SAN CARLOS, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage…
Scinai Immunotherapeutics Announces Closing of $1.33 Million Registered Direct Offering
JERUSALEM, Sept. 19, 2023 (GLOBE NEWSWIRE) — via IBN – Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI),…
Galapagos appoints Simon Sturge to its Board of Directors
Mechelen, Belgium; 19 September 2023, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced…